FDA Joins Three New Collaborative Communities
Per the notice below, the United States Food and Drug Administration (FDA) has announced participation in three new collaborative communities.
FDA Participates in Three New Collaborative Communities
 Recently, the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) began participating in three new collaborative communities in the medical device ecosystem:
|
Collaborative Communities
A collaborative community is a continuing forum in which private- and public-sector members, which can include the FDA, work together on medical device challenges to achieve common objectives and outcomes. They are convened by interested stakeholders and may exist indefinitely, produce deliverables as needed, and tackle challenges with broad impacts. Participation in collaborative communities was one of CDRH’s strategic priorities for 2018-2020 and the FDA currently participates as a member of 17 collaborative communities. The FDA is open to participating in others. If you have a collaborative community in which you would like the FDA to participate, e-mail: CDRHCollabCommunities@fda.hhs.gov.
.png?sfvrsn=4447de7f_1)
